Mila Habsy, a social media manager from Manchester, experienced a rapid weight increase of over three stone after discontinuing birth control at age 19. Her struggle was eventually linked to a diagnosis of polyendocrine metabolic ovarian syndrome (PMOS), a condition that disrupts hormones and metabolism.
The shift from PCOS to polyendocrine metabolic ovarian syndrome
The medical community is evolving in how it classifies this condition ,moving from the more narrow definition of polycystic ovarian syndrome (PCOS) to the broader polyendocrine metabolic ovarian syndrome (PMOS). As the report highlights, this change reflects a growing understanding that the disorder is not merely an ovarian issue but a systemic one that impacts the cardiovascular system, mental health, and overall metabolism.
This shift in terminology is significant because it moves the conversation away from reproductive fertility alone and toward a holistic endocrine perspective. By recognizing PMOS as a metabolic disorder, healthcare providers can better address how the body processes glucose and stores fat, which often explains why traditional weight-loss methods fail for those with the condition.
How three stone of weight gain defied Mila Habsy's exercise
For Mila Habsy, the onset of PMOS manifested as a stubborn accumulation of weight around her stomach, hips, and thighs. Despite implementing a rigorous regimen of long-distance running and strict caloric restriction—including skipping breakfast and eating small portions—Habsy found her frame becoming rounded and puffy. According to the report, she gained a little over three stone in under a year, leading to significant insecurity and frustration.
This experience underscores a common struggle for women with PMOS: the "PMOS belly." This abdominal fat distribution is often resistant to diet and exercise because it is driven by hormonal imbalances rather than simple caloric surplus. For Habsy, the diagnosis provided a necessary explanation for why her extreme efforts to lose weight were ineffective.
Why 1 in 8 UK women may face PMOS challenges
The scale of this issue is substantial, with Professor Dipa Kamdar, a senior lecturer at Kingston University, stating that PMOS affects approximately one in eight women in the UK. However, Kamdar warns that nearly half of these women may exhibit no obvious symptoms, making the condition difficult to detect without specific medical screening.
The biological mechanism involves an overproduction of androgens, such as testosterone. Dr. Adam Balen of the Leeds Teaching Hospitals NHS Trust explains that these elevated androgen levels can redirect fat storage away from the hips and toward the abdomen, creating an "apple-shaped" pattern. furthermore, as reported, these hormonal shifts can lead to insulin resistance, meaning fat cells do not burn energy efficiently and gut bacteria may become abnormal, further complicating weight management.
What treatment protocols helped Mila Habsy recover?
While the report notes that Mila Habsy has since returned to her usual weight and now models part-time, it leaves a critical gap regarding the specific medical interventions she used. The report explicitly states her transformation was not due to GLP-1 medicines or harsh dieting, but it does not detail the specific medications, hormonal therapies, or nutritional protocols that enabled her recovery.
Additionally, while the text mentions that the condition is manageable with "the right understanding and support," it does not specify what that support looks like in a clinical setting. Whether this involves metformin for insulin resistance, specific dietary changes for glucose management, or other endocrine treatments remains unverified in the source material.
Comments 0